Literature DB >> 20382057

Class 2 IGF-1 isoforms are dispensable for viability, growth and maintenance of IGF-1 serum levels.

L Temmerman1, E Slonimsky, N Rosenthal.   

Abstract

Insulin-like growth factor 1 (IGF-1) is a pleiotropic factor involved in growth, cell survival and cellular differentiation. It exerts its functions through endocrine, paracrine or autocrine mechanisms. Circulating IGF-1 is essential for normal fetal and postnatal growth, although the published phenotypes of IGF-1 null animals have been only partially penetrant, presumably due to mixed genetic backgrounds. Molecular dissection of IGF-1 action is complicated by the existence of at least nine different IGF-1 isoforms, generated in both humans and rodents by usage of alternate promoters, differential splicing and different post-translational modifications. Several lines of evidence suggest that the Class 2 IGF-1 isoform is specifically destined for circulation, supporting an endocrine role of IGF-1 in normal growth processes. Using Cre/LoxP conditional gene targeting of exon 2 of the IGF-1 gene, we have generated a Class 2 IGF-1 knockout mouse line in a pure C57/Bl6 genetic background, where the specific removal of exon 2 ablated Class 2 IGF-1 isoform. Class 2 IGF-1 knockout mice exhibited normal development and postnatal growth patterns and had normal IGF-1 circulating levels, due to compensatory upregulation of Class 1 transcripts. In contrast, progeny of a total IGF-1 knockout line lacking exon 3 in the same genetic background were predictably smaller, displayed dramatically reduced IGF-1 receptor phosphorylation and all died perinatally, apparently due to respiratory failure. These results confirm that Class 2 signal peptide is not necessary for systemic circulation of IGF-1, revealing an internal compensation system for maintaining IGF-1 serum concentrations. We also uncover a vital requirement of IGF-1 for perinatal viability, previously obscured by modifiers in heterogeneous genetic backgrounds. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20382057     DOI: 10.1016/j.ghir.2010.03.002

Source DB:  PubMed          Journal:  Growth Horm IGF Res        ISSN: 1096-6374            Impact factor:   2.372


  16 in total

Review 1.  The complexity of the IGF1 gene splicing, posttranslational modification and bioactivity.

Authors:  Anastassios Philippou; Maria Maridaki; Spiros Pneumaticos; Michael Koutsilieris
Journal:  Mol Med       Date:  2014-05-07       Impact factor: 6.354

2.  Insulin-like growth factor-1 mRNA isoforms and insulin-like growth factor-1 receptor mRNA expression in chronic hepatitis C.

Authors:  Aldona Kasprzak; Agnieszka Adamek; Wiesława Przybyszewska; Przemysław Pyda; Jacek Szmeja; Agnieszka Seraszek-Jaros; Agata Lanzafame; Anna Surdacka; Iwona Mozer-Lisewska; Maria Koczorowska
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

3.  Monocyte/Macrophage-derived IGF-1 Orchestrates Murine Skeletal Muscle Regeneration and Modulates Autocrine Polarization.

Authors:  Joanne Tonkin; Lieve Temmerman; Robert D Sampson; Enrique Gallego-Colon; Laura Barberi; Daniel Bilbao; Michael D Schneider; Antonio Musarò; Nadia Rosenthal
Journal:  Mol Ther       Date:  2015-04-21       Impact factor: 11.454

4.  Spatiotemporal patterns of macrophage migration inhibitory factor (Mif) expression in the mouse placenta.

Authors:  Miriam R Faria; Mara S Hoshida; Eloisa Av Ferro; Francesca Ietta; Luana Paulesu; Estela Bevilacqua
Journal:  Reprod Biol Endocrinol       Date:  2010-08-04       Impact factor: 5.211

5.  Delayed recovery of skeletal muscle mass following hindlimb immobilization in mTOR heterozygous mice.

Authors:  Susan M Lang; Abid A Kazi; Ly Hong-Brown; Charles H Lang
Journal:  PLoS One       Date:  2012-06-22       Impact factor: 3.240

6.  E-peptides control bioavailability of IGF-1.

Authors:  Marianne Smedegaard Hede; Ekaterina Salimova; Agnieszka Piszczek; Emarald Perlas; Nadine Winn; Tommaso Nastasi; Nadia Rosenthal
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

7.  Zcchc11 uridylates mature miRNAs to enhance neonatal IGF-1 expression, growth, and survival.

Authors:  Matthew R Jones; Matthew T Blahna; Elyse Kozlowski; Kori Y Matsuura; Joseph D Ferrari; Samantha A Morris; John T Powers; George Q Daley; Lee J Quinton; Joseph P Mizgerd
Journal:  PLoS Genet       Date:  2012-11-29       Impact factor: 5.917

8.  Evidence for the Possible Biological Significance of the igf-1 Gene Alternative Splicing in Prostate Cancer.

Authors:  Anastassios Philippou; Athanasios Armakolas; Michael Koutsilieris
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-20       Impact factor: 5.555

9.  The Regulation of IGF-1 Gene Transcription and Splicing during Development and Aging.

Authors:  A M Oberbauer
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-26       Impact factor: 5.555

10.  Expression of various insulin-like growth factor-1 mRNA isoforms in colorectal cancer.

Authors:  Aldona Kasprzak; Witold Szaflarski; Jacek Szmeja; Małgorzata Andrzejewska; Wiesława Przybyszewska; Maria Koczorowska; Michał Drews; Elżbieta Kaczmarek
Journal:  Contemp Oncol (Pozn)       Date:  2012-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.